Affordable Access

Publisher Website

Clinician’s overview of platelet support

Authors
Journal
Transfusion Science
0955-3886
Publisher
Elsevier
Publication Date
Volume
18
Issue
3
Identifiers
DOI: 10.1016/s0955-3886(97)00030-1
Disciplines
  • Medicine

Abstract

Abstract In a period of 2 years, 48 patients over age 55 were treated for acute myeloblastic leukaemia or myelodysplastic syndrome with greater than 10% blasts. 15 patients were treated with intestine chemotherapy, requiring a mean of 48 units of platelets per course. 33 patients were treated by supportive care alone of whom 19 required a mean of 380 units of platelets each. Long term supportive care is a feasible option in elderly leukaemia. Because of dysplasia some patients bleed at a higher threshold than younger patients. A further hazard is the use of i.v. hydrocortisone to suppress transfusion reactions. Such unintentional use of steroids in patients with dysplastic neutrophiles and monocytes may predispose to fungal infections.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Clinician's overview of platelet support.

on Transfusion science September 1997

Winning the support of clinicians for I.T.

on Health data management September 2008

Xylitol and dental caries: an overview for clinici...

on Journal of the California Dent... March 2003

Blood platelets: an overview.

on Journal of reconstructive micr... April 1989
More articles like this..